Ripple Therapeutics Corporation
$25,000.00 CAD
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2025-2026
- Agreement period
- April 16, 2025 – January 31, 2026
- Reference
- nrc-cnrc:172-2025-2026-Q1-1029660
Published purpose
Ripple Therapeutics Corporation is a clinical stage, privately held company that is focused on ophthalmic therapeutics with controllable, sustainable drug delivery. A new technical resource will apply her scientific skill set to support the development of novel prodrug compounds. She will work closely with R&D team members, under direct supervision, to advance project objectives and milestones. The position will design and execute experiments for the development of sustained delivery implants, analyze data to inform additional research and prepare records, reports and operating documentation to support new discovery within Ripple’s drug delivery platform technology.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.